Wollenberg, A., Cork, M., Flohr, C., Bewley, A., Blauvelt, A., Hong, C.- ho, Imafuku, S., Schuttelaar, M. L., Simpson, E., Soong, W., Amoudruz, P., Wendicke Lophaven, K. ., Kurbasic, A., Soldbro, L., Strange Vest, N. ., & Paller, A. (2023). Safety of tralokinumab in pediatric patients aged 12-17 years with moderate to severe atopic dermatitis: results from the phase 3 ECZTRA 6 trial. SKIN The Journal of Cutaneous Medicine, 7(2), s140. https://doi.org/10.25251/skin.7.supp.140